[HTML][HTML] The conduct and reporting of mediation analysis in recently published randomized controlled trials: results from a methodological systematic review

TT Vo, C Superchi, I Boutron, S Vansteelandt - Journal of clinical …, 2020 - Elsevier
Objectives To describe the methodological characteristics of mediation analyses (MAs)
reported in recent randomized controlled trials (RCTs) and to propose recommendations on …

Clinical characteristics and management strategies for adult obese asthma patients

S Farzan, T Coyle, G Coscia, A Rebaza… - Journal of asthma and …, 2022 - Taylor & Francis
The rates of asthma and obesity are increasing concurrently in the United States.
Epidemiologic studies demonstrate that the incidence of asthma increases with obesity …

The effects of obesity in asthma

A Mohan, J Grace, BR Wang, N Lugogo - Current allergy and asthma …, 2019 - Springer
Abstract Purpose of Review Rising costs and increasing morbidity makes the identification
and treatment of high-risk asthma phenotypes important. In this review, we outline the …

Metabolic dysfunction and asthma: current perspectives

H Pite, L Aguiar, J Morello, EC Monteiro… - Journal of Asthma …, 2020 - Taylor & Francis
The increasing knowledge of the mechanisms involved in metabolism is shifting the
paradigms by which the pathophysiology of many pulmonary diseases is understood …

[HTML][HTML] REGN1908/1909 prevented cat allergen–induced early asthmatic responses in an environmental exposure unit

FJ de Blay, A Gherasim, N Domis, P Meier… - Journal of Allergy and …, 2022 - Elsevier
Background The dominant allergen in cat dander, Felis domesticus allergen 1 (Fel d 1), is a
persistent trigger for allergic rhinitis and asthma symptoms. Objective We evaluated the …

[HTML][HTML] Obesity-related asthma and its relationship with microbiota

J Huang, X Zhou, B Dong, H Tan, Q Li… - Frontiers in Cellular …, 2024 - frontiersin.org
Obesity and asthma are global public health problems. Obesity-related asthma is a special
phenotype of asthma with a complex pathogenesis. Its occurrence and development are …

[HTML][HTML] Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and …

FC Albers, A Papi, C Taillé, DJ Bratton, ES Bradford… - Respiratory …, 2019 - Springer
Background We assessed the efficacy of the licensed mepolizumab dose (100 mg
subcutaneously [SC]) in patients with severe eosinophilic asthma according to body …

Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers

P Santus, M Saad, G Damiani, V Patella… - Pharmacological …, 2019 - Elsevier
Asthma is a respiratory disorder with considerable heterogeneity in aetiology, triggers,
clinical characteristics and response to therapy. This diversity reflects different inflammatory …

Obesity and asthma

AE Dixon, LG Que - Seminars in respiratory and critical care …, 2022 - thieme-connect.com
Obesity is a major risk factor for the development of asthma, and the prevalence of obesity is
higher in people with asthma than in the general population. Obese people often have …

Type 2 biomarkers for the indication and response to biologics in CRSwNP

CL Guo, FF Liu, DY Wang, Z Liu - Current Allergy and Asthma Reports, 2023 - Springer
Abstract Purpose of Review Three biologics targeting type 2 inflammation have been
approved for the treatment of severe and uncontrolled chronic rhinosinusitis with nasal …